pergolide has been researched along with Hallucinations in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burlon, M; Göhring, K; Gruschka, P; Kaiser, S; Pfüller, U; Roesch-Ely, D; Weisbrod, M | 1 |
| Bernardi, S; Meco, G | 1 |
| Comella, CL; Ristanovic, RK; Tanner, CM | 1 |
| Cabrera-Valdivia, F; Fernández-Lliria, A; Gasalla, T; Jiménez-Jiménez, FJ; Ortí-Pareja, M; Tallón-Barranco, A | 1 |
| Graham, JM; Grünewald, RA; Sagar, HJ | 1 |
| Hanna, PA; Jankovic, J; Ondo, WG; Ratkos, L | 1 |
| McHale, DM; Sage, JI | 1 |
| Glantz, RH; Goetz, CG; Klawans, HL; Tanner, CM | 1 |
1 trial(s) available for pergolide and Hallucinations
| Article | Year |
|---|---|
Switching from pergolide to pramipexole in patients with Parkinson's disease.
Topics: Accidental Falls; Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Edema; Female; Hallucinations; Humans; Male; Middle Aged; Nausea; Parkinson Disease; Pergolide; Pramipexole; Prospective Studies; Receptors, Dopamine; Sweating; Thiazoles; Treatment Outcome | 2001 |
7 other study(ies) available for pergolide and Hallucinations
| Article | Year |
|---|---|
Pergolide as adjuvant therapy to amisulpride in the treatment of negative and depressive symptoms in schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Comorbidity; Depressive Disorder; Dopamine Agonists; Drug Therapy, Combination; Frontal Lobe; Hallucinations; Humans; Male; Neural Pathways; Pergolide; Psychiatric Status Rating Scales; Receptors, Dopamine D1; Receptors, Dopamine D2; Schizophrenia, Paranoid; Sulpiride; Treatment Outcome | 2006 |
Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
Topics: Affect; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Antipsychotic Agents; Clomipramine; Clozapine; Delusions; Depressive Disorder; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Psychiatric Status Rating Scales; Psychotic Disorders | 2007 |
Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations.
Topics: Aged; Bromocriptine; Carbidopa; Hallucinations; Humans; Levodopa; Parkinson Disease; Pergolide; Polysomnography; Sleep; Sleep, REM | 1993 |
Cenesthetic hallucinations in a patient with Parkinson's disease.
Topics: Aged; Clozapine; Female; Hallucinations; Humans; Levodopa; Parkinson Disease; Pergolide | 1997 |
Hallucinosis in idiopathic Parkinson's disease.
Topics: Aged; Bromocriptine; Cognition Disorders; Depressive Disorder; Dopamine Agonists; Female; Hallucinations; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Psychomotor Disorders; Retrospective Studies; Severity of Illness Index; Time Factors | 1997 |
Hallucinations and confusion after pergolide withdrawal.
Topics: Aged; Cognition Disorders; Confusion; Female; Hallucinations; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Substance Withdrawal Syndrome | 1988 |
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Outcome and Process Assessment, Health Care; Parkinson Disease; Pergolide; Time Factors | 1985 |